scispace - formally typeset
K

Karin M. Vermeulen

Researcher at University Medical Center Groningen

Publications -  117
Citations -  2687

Karin M. Vermeulen is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Cost effectiveness & Randomized controlled trial. The author has an hindex of 24, co-authored 104 publications receiving 1990 citations. Previous affiliations of Karin M. Vermeulen include University of Groningen.

Papers
More filters
Journal ArticleDOI

Dutch Tariff for the Five-Level Version of EQ-5D

TL;DR: A Dutch tariff for the EQ-5D-5L is established on the basis of composite time trade-off (cTTO) to estimate the impact of health care interventions on quality of life, for example, in context of economic evaluations.
Journal ArticleDOI

Preferences of heart failure patients in daily clinical practice : quality of life or longevity?

TL;DR: This study uses utility measurement to assess the preferences of heart failure patients regarding quality of life or longevity using the perspective of a patient.
Journal ArticleDOI

Costs and Effects of Abdominal versus Laparoscopic Hysterectomy: Systematic Review of Controlled Trials

TL;DR: The shorter hospital stay in the LH group compensates for the increased procedure costs, with less morbidity, and LH points in the direction of cost effectiveness, however further research is warranted with a broader costs perspective.
Journal ArticleDOI

A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist.

TL;DR: It is hypothesized that a nurse practitioner would improve the quality of life of a child with eczema more than a dermatologist because of a structured intervention and more consultation time.
Journal ArticleDOI

Initiation of home mechanical ventilation at home: a randomised controlled trial of efficacy, feasibility and costs

TL;DR: This study is the first to show that initiation of HMV at home in a selective group of patients with chronic respiratory failure is as effective for gas exchange and quality of life as hospital initiation, and that more than € 3000 per patient can be saved compared to standard care.